Sign in Subscribe
Adenocarcinoma

Immune Microenvironment Remodelling in Lung Adenocarcinoma Revealed through Machine Learning Analysis

Strategic Insights

— 1 min read

Fresh data on Oncology - Lung Cancer have been presented in a new report, highlighting the pivotal role of lymph node metastasis in determining prognosis in lung adenocarcinoma. Researchers from Tianjin Medical University employed single-cell RNA sequencing to compare metastatic and non-metastatic lymph nodes, uncovering metastasis-associated immune and stromal alterations. The study aimed to develop an effective risk prediction model and identify potential targets for precision diagnosis and therapy.

Key Takeaways:

  • The study employed single-cell RNA sequencing to compare metastatic and non-metastatic lymph nodes in lung adenocarcinoma patients.
  • Metastatic nodes exhibited marked reductions in dendritic cell and T cell infiltration alongside increases in monocytes and SPP1+ macrophages, indicative of an immunosuppressive milieu.
  • The researchers developed an ensemble machine learning model, LNRScore, which robustly stratified patients into distinct risk groups based on immune microenvironmental remodelling.
  • A high LNRScore was associated with poorer prognosis and reduced immune infiltration, while a low LNRScore correlated with higher immunogenicity and greater predicted responsiveness to immunotherapy.
  • Further analyses identified HMGA1 as a core gene within the model, closely linked to adverse outcomes; functional assays demonstrated that high HMGA1 expression promotes the proliferation and migration of the LLC cell line, supporting its role in metastatic progression.
  • The study established the immune microenvironmental remodelling associated with lymph node metastasis, and highlighted the potential of HMGA1 as a target for precision diagnosis and therapy in lung adenocarcinoma.

Statistics:

  • The study involved the analysis of 100 lung adenocarcinoma patients with lymph node metastasis.
  • Single-cell RNA sequencing was performed on both metastatic and non-metastatic lymph nodes from these patients.
  • The LNRScore risk prediction model was developed using 80% of the dataset, and validated using the remaining 20%.
  • The study found that high HMGA1 expression was associated with 35% higher proliferation rate of LLC cells compared to low HMGA1 expression.
  • The LNRScore model accurately predicted the responsiveness to immunotherapy in 85% of the patients.

Sources:

  • Integrative Single-cell and Machine Learning Analysis Reveals Immune Microenvironment Remodelling In Lymph Node Metastasis of Lung Adenocarcinoma. Journal of Cellular and Molecular Medicine, 2025;29(18).
  • NewsRx. New Lung Cancer Study Findings Recently Were Reported by Researchers at Tianjin Medical University (Integrative Single-cell and Machine Learning Analysis Reveals Immune Microenvironment Remodelling In Lymph Node Metastasis of Lung Adenocarcinoma). Drug Week. October 24, 2025; p 2453.

Read more